Author:
Barchukov V. V.,Tsorin I. B.,Likhosherstov A. M.,Vititnova M. B.,Mokrov G. V.,Gudasheva T. A.,Kryzhanovskii S. A.
Publisher
Springer Science and Business Media LLC
Subject
General Biochemistry, Genetics and Molecular Biology,General Medicine
Reference15 articles.
1. Korokin MV, Pokrovskii MV, Kochkarov VI, Gudyrev OS, Pokrovskaia TG, Korokina LV, Polyanskaya OS. Research of endothelio-and cardioprotective effects of enalapril, lozartan and amlodipin at modelling hyperhomocystein induced endothelial dysfunction. Ross. Med.-Biol. Vestn. 2014;(1):60-65. Russian.
2. Bhandari B, Subramanian L. Ranolazine, a partial fatty acid oxidation inhibitor, its potential benefit in angina and other cardiovascular disorders. Recent. Pat. Cardiovasc. Drug Discov. 2007;2(1):35-39.
3. Fukushima A, Milner K, Gupta A, Lopaschuk GD. Myocardial energy substrate metabolism in heart failure: from pathways to therapeutic targets. Curr. Pharm. Des. 2015;21(25):3654-3664.
4. Jaswal JS, Keung W, Wang W, Ussher JR, Lopaschuk GD. Targeting fatty acid and carbohydrate oxidation — a novel therapeutic intervention in the ischemic and failing heart. Biochim. Biophys. Acta. 2011;1813(7):1333-1350.
5. Kolwicz SC Jr, Purohit S, Tian R. Cardiac metabolism and its interactions with contraction, growth, and survival of cardiomyocytes. Circ. Res. 2013;113(5):603-616.
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献